METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH)
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH) explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH) trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gut germs linked to liver damage in new study
Knowledge-focused Not yet recruitingThis study looks at whether gut bacteria in people with fatty liver disease (MASLD) produce certain chemicals that may harm the liver. Researchers will collect stool samples from 24 participants (patients and healthy volunteers) and grow the bacteria in the lab to measure these c…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH)
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 26, 2026 05:02 UTC
-
Healthy volunteers test new MASH drug in early safety trial
Knowledge-focused Not yet recruitingThis early-stage study tests QL2401, a potential treatment for a liver condition called MASH, in 70 healthy Chinese adults. Participants receive either the drug or a placebo to check for side effects and how the body processes it. The goal is safety and dosing information, not tr…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH)
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC